Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma

By sjmartinez • April 10, 2024

Gleason L, Afifi L, Banner L, Talasila S, Joffe D, Bhatti S, Alpdogan O, Porcu P, Nikbakht N. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma. Mol Clin Oncol. 2024 Mar 19;20(5):35. doi: 10.3892/mco.2024.2733. PMID: 38596625; PMCID: PMC11002836.

Tags: anaplastic large cell, anaplastic lymphoma kinase, CD30+, Dermatology, lymphoma, primary cutaneous anaplastic large cell lymphoma, Publications, Resident, systemic anaplastic large cell lymphoma

Single-cell and spatial profiling reveal cDC2A-CXCL13+CD8+ T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus

Jiang R, Bogle R, Xing X, Kirma J, Fox J, Harms PW, Do T, Billi AC, Kahlenberg JM, Modlin RL, Teles R, West J, Mangold[...]

Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis

Conde G, Carmenate Y, Bello G, Armstrong AW. Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis. J Dermatol. 2026 Mar 13. doi:[...]

Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis

Silverberg JI, Bieber T, Eyerich K, Armstrong AW, Nickoloff BJ, Natalie CR, Gallo G, Okragly A, Wolf E, Xu C, Moser BA, Rueda MJ, Elmaraghy[...]